Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Marmoset Research - Scope and Challenges
Published on: June 9, 2023
Infection with MERS-CoV causes lethal pneumonia in the common marmoset
Darryl Falzarano1, Emmie de Wit1, Friederike Feldmann2
1Disease Modeling and Transmission, Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.
Abstract:
The availability of a robust disease model is essential for the development of countermeasures for Middle East respiratory syndrome coronavirus (MERS-CoV). While a rhesus macaque model of MERS-CoV has been established, the lack of uniform, severe disease in this model complicates the analysis of countermeasure studies. Modeling of the interaction between the MERS-CoV spike glycoprotein and its receptor dipeptidyl peptidase 4 predicted comparable interaction energies in common marmosets and humans. The suitability of the marmoset as a MERS-CoV model was tested by inoculation via combined intratracheal, intranasal, oral and ocular routes. Most of the marmosets developed a progressive severe pneumonia leading to euthanasia of some animals. Extensive lesions were evident in the lungs of all animals necropsied at different time points post inoculation. Some animals were also viremic; high viral loads were detected in the lungs of all infected animals, and total RNAseq demonstrated the induction of immune and inflammatory pathways. This is the first description of a severe, partially lethal, disease model of MERS-CoV, and as such will have a major impact on the ability to assess the efficacy of vaccines and treatment strategies as well as allowing more detailed pathogenesis studies.
Insights
A new common marmoset model for Middle East respiratory syndrome coronavirus (MERS-CoV) infection causes severe pneumonia. This severe MERS-CoV disease model is crucial for developing effective vaccines and treatments.
Area of Science:
- Virology
- Infectious Diseases
- Animal Models
Background:
- A robust disease model is critical for developing Middle East respiratory syndrome coronavirus (MERS-CoV) countermeasures.
- Existing rhesus macaque models exhibit variable disease severity, hindering countermeasure analysis.
Purpose of the Study:
- To evaluate the common marmoset as a susceptible and responsive model for MERS-CoV infection.
- To establish a severe, partially lethal MERS-CoV disease model for pathogenesis and therapeutic studies.
Main Methods:
- Computational modeling predicted MERS-CoV spike glycoprotein and human dipeptidyl peptidase 4 receptor interactions.
- Common marmosets were inoculated via combined intratracheal, intranasal, oral, and ocular routes.
- Disease progression, viral loads, lung pathology, and host immune responses were assessed.
Main Results:
- Most marmosets developed progressive, severe pneumonia, with some requiring euthanasia.
- Extensive lung lesions and high viral loads were observed in all necropsied animals.
- Viremia and induction of immune and inflammatory pathways were detected via RNAseq.
Conclusions:
- The common marmoset provides a valuable, severe, and partially lethal disease model for MERS-CoV.
- This model will significantly advance the assessment of MERS-CoV vaccines and therapeutics.
- It facilitates detailed studies into MERS-CoV pathogenesis.
More Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Viral Meningitis
Pneumonia III: Complications and Assessment

